Imdevimab
Modify Date: 2024-07-17 11:51:00
Imdevimab structure
|
Common Name | Imdevimab | ||
|---|---|---|---|---|
| CAS Number | 2415933-40-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ImdevimabImdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases[1]. |
| Name | Imdevimab |
|---|
| Description | Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
SARS-CoV-2[1] |
| References |
| No Any Chemical & Physical Properties |